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PCNA (7 dayslt A-Xa (units/mll
Media Intima 1hour 24 hours
CO 4.04 ± 2.6 25.5 ± 8.4 0.02 ± 0.03 0.06 ± 007
LOC 4.8 ± 4.1 16.9 ± 11.9ttt 1.25 ± 0.27* 0.12±005
COM 1.6 ± 2.2tt 7.3 ± 9.2tttt 1.43 ± 0.12* 0.20 ± 0.10**
2:45
t (+) PCNA nuciei/JLm2; ttp = 0.06 vs. CO; tttp = 0.09 vs. CO; ttttp = 0.001 vs CO;
*p > 0.005 vs. CO; **p > 0.05 vs. CO
We conclude that: (1) Locally delivered enoxaparin tended to reduce
smooth muscle cell proliferation, and significantly inhibited smooth mus-
cle cell proliferation with concomitant systemic enoxaparin treatment, as
assessed by PCNA staining; (2) Supporting local enoxaparin effect with sys-
temic treatment at critical time point for smooth muscle cell proliferation
seems necessary: and (3) anti-Factor Xa activity levels suggest sustained
(up to 24 hours) enoxaparin activity only with combined local and systemic
treatment.
1793-41 Local Delivery of C-myb Antisense attenuates
Neo-Intimal Thickening In a Porcine Model of
Coronary Angioplasty
Julian Gunn, Cathy M. Holt, Lynda Shepherd, Sheila E. Francis, Geoffrey H. Smith,
David C. Cum berla nd Sections of Cardiac Surgery and Cardiology, University of
Sheffield, Northern General Hospital, Sheffield, UK
Intimal smooth muscle cell proliferation and extracellular matrix production
compose the restenotic lesion. The proto-oncogene c-myb is up-regulated
in proliferating cells and is a common "downstream" link in several mito-
genic pathways. We have recently shown that c-myb antisense specifically
inhibits proliferation of several types of human vascular cells in vitro. The de-
velopment of catheter-based local drug delivery systems allows us to test
the feasibility and efficacy of local intra-mural delivery of c-myb antisense in
a porcine model of coronary angioplasty
We first tested an unmodified HPLC-purified 18-mer antisense oligonu-
cleotide directed against the human sequence of c-myb in porcine aortic
smooth muscle cells in culture. More than 90% inhibition of cellular prolifer-
ation was observed at 5 JLM with no adverse effect on cellular viability. This
effect was not seen with sense oligonucleotides.
The in vivo delivery system used was the Transport (CVD) double skinned
balloon catheter, allowing high pressure oversized balloon dilatation followed
by low pressure delivery of 500 JLg antisense in 2 ml saline over 1 - 2 mins.
Ex vivo and in vivo delivery of fluorescein labelled oligonucleotide using this
system demonstrated successful intramural localisation. Wethen performed
oligo delivery in vivo into a single porcine coronary artery (n = 10); the con-
trol group underwent angioplasty using a conventional balloon without drug
delivery (n = 12). Animals were sacrificed at 4 weeks. Quantitative morpho-
metric analysis of serial transverse histological sections demonstrated a con-
sistent reduction in absolute and percent intimal thicknesses and areas to-
gether with a significant reduction in mean (SEM) intimal/medial thickness
ratio from 0.37 (0.09) to 0.1310.03) (p < 0.05) in the treatment group.
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1793-31 Percutaneous Arterial Gene Transfer to the Media
Using Hydrogel-Coated Balloon Delivery of
Plasmld-Polylysine Complexes and Chloroquine
o. Tahlil, P Erbacher, M. Brami, J.Y. Scoazec, A.C. Roche, A. Legrand, J,J. Barry,
M. Monsigny, P Midoux, PG. Steg. Faculte X Sichat, Paris & CNRS-Universite
d'OrMans, FR
Gene therapy for restenosis requires efficient and safe percutaneous gene
transfer to medial cells, Adenoviral vectors may not be absolutely safe, and,
most non-viral methods (such as direct DNA transfer or liposomes) for arterial
gene transfer have a very low efficiency, We sought to determine whether the
use of plasmid-polylysine complexes, associated with treatments designed
to prevent lysosomal degradation (such as chloroquine) could be used for
percutaneous local arterial gene transfer to the media using hydrogel-coated
balloons. 16 rabbits underwent iliac transluminal angioplasty using a 3,0 mm
hydrogel-coated balloon, with a 30 min inflation, The hydrogel had been
coated with 25 JLI of a plasmid-polylysine complex (containing 5 JLg DNA
of the pgalactosidase reporter gene driven by the SV40 promoter) and with
chloroquine (100 JLM). Rabbits were sacrificed at 3 days, and arteries (and
other organs) assayed for reporter gene expression by X-gal staining. In all
the animals, expression of the transgene was visible on macro and micro-
scopic examinations. It was strictly confined to the media in the target arterial
segment.
Conclusion: Percutaneous site-specific arterial gene transfer to the media
can be achieved using plasmid-polylysine complexes and chloroquine deliv-
ered via a hydrogel-coated angioplasty balloon.
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Conclusion: Local, low pressure heparin delivery following balloon angio-
plasty may reduce incidence of restenosis and decrease the need for re-
angioplasty.
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1793-1 I Local, Low Pressure Heparin Delivery Following
Angioplasty In Man: The Solution to Restenosls?
Edoardo Camenzind, Wim van der Giesen, Jurgen Ligthart, Peter Ruygrok,
Peter de Jaegere, Pim de Feyter, Patrick W. Serruys. Thoraxcentre, Erasmus
University, Rotterdam, Netherlands
Of 38 patients (28 men, 58 ± 10 years) treated by conventional balloon an-
gioplasty followed by local heparin delivery (1660 ± 656 IU at low pressure
110 ± 48 mmHg during 30 ± 7 min) through the Dispatch 'w (Scimed) 20 (12
men, 57 ± 10 years). have undergone 6 month review. One 78 year old pa-
tient with aortic stenosis died in hospital 7 weeks after the procedure from
acute heart failure following 2 transfusions for the exacerbation of ulcerative
colitis. Of the 19 remaining patients clinical follow-up was available for all
and control angiography was performed in 14 (74%), Of the 5 who declined,
all asymptomatic, 3 had a negative MIBI scintigram and 2 refused further
examination. Symptoms: Five (26%) of the 19 patients were symptomatic
(3 exertional and 2 atypical angina) and angiography showed 4 new lesions
and 1 restenosis (diameter stenosis 60%) of the target lesion, Angiogram:
No aneurysmatic dilatation at the site of delivery was visualized, However
4 out of 14 (29%) lesions had a increase in MLD (range: 0.17-0,51 mm).
Mean MLD measured by quantitative analysis (CAAS II) in matched projec-
tions (post-procedure vs 6 month follow-up) was 2,0 ± 0.5 mm vs 1.73 ±
0.4 mm representing a mean late loss of 0.27 mm. The incidence of resteno-
sis, defined as a diameter stenosis at follow-up of >50% was 7%. None of
patients required re-angioplasty of the treated segment.
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1793-21 Efficacy of Locally Delivered Low Molecular Weight
Heparin (Enoxaparln) on Smooth Muscle Cell
Proliferation
Mun K, Hong, S. Chiu Wong, Christian C. Haudenschild, Orville D. 8ramwell,
Alexey Tjurmin, James J. Barry, Myong H. Nam, Theodore E. Spiro, Martin B. Leon
Washington Hospital Center. Washington, D. C.; American Red Cross, Rockville, MD
Enoxaparin (EN), when systemically administered, has been shown to re-
duce restenosis in preclinical studies. Previously, we demonstrated that 3H_
EN locally delivered via channeled balloon (CB), a dual-purpose local deliv-
ery catheter capable of simultaneous angioplasty, was retained intramurally
for at least 24 hours, To determine whether locally delivered EN can reduce
restenosis by inhibiting smooth muscle cell proliferation, 3 groups of rab-
bits underwent balloon injury of bilateral iliac arteries with CB (balloon/artery
= 1.1), followed by assigned treatment [4 control rabbits (CO) receiving lo-
cal saline in 8 arteries, 4 local EN rabbits (LOC) receiving one-time local EN
@ 10 mglkg at the time of angioplasty in 8 arteries, and 5 combined treat-
ment rabbits (COM) receiving one-time local EN @ 10 mglkg in 10 arteries
and systemic EN @ 10 mglkg s.c. daily for one week). One week later, the
animals were euthanized and the iliac arteries were perfusion fixed for prolif-
erating cell nuclear antigen (PCNA) staining, Anti-factor Xa activity (A-Xa) as a
measure of successful EN delivery was measured at baseline (0.024 ± 0.02
units/ml), 1 hour and 24 hours after the procedure.
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Conclusion: These results provide a rationale for clinical trials of local de-
livery of c-myb antisense for the reduction of restenosis after angioplasty.
Adult Congenital Heart Disease
'p < 0.05 treatment vs sham local delivery, +p < 0.05 treatment vs IL local delivery
We conclude that platelet adhesion at sites of deep arterial injury is re-
duced by IL delivered via encapsulated pits, immediately following balloon
injury. Maximum beneficial effect is seen when pits are delivered locally.
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1794-1 I Outcome of Pregnancy in Women with Complex
Pulmonary Atresia
Heidi M. Connolly, Carole A. Warnes Mayo Clinic, Rochester, MN
To define the outcome of pregnancy in patients (pts)with complex pulmonary
atresia (PA); i.e. PA with VSD and congenital systemic to pulmonary collater-
als, we reviewed data on 76 such pts 2:16 yrs old, seen at the Mayo Clinic
between 1980-92. There were 62 pts who were advised against or had not
attempted pregnancy, no pts reported infertility. Fourteen pts had 24 preg-
nancies resulting in 10 live births, (inclUding one twin pregnancy). There was
one neonatal death due to abruptio placenta at 27 wks. Seven deliveries (in-
cluding the twins; i.e. 8 births), were vaginal and 2 were by cesarean section.
Six pregnancies were terminated due to unoperated maternal PA. Miscar-
riage occurred in 9/18 (50%) of uninterrupted pregnancies in 7 pts (3 in pts
without prior cardiac surgery, 4 in pts after palliation, and 2 after complete
repair).
Six pts had successful pregnancies; 2 unoperated pts had 3 deliveries (in-
cluding twins; i.e. 4 births). 2 palliated pts had 3 deliveries, and 2 pts had 2
successful and 2 unsuccessful pregnancies after complete repair. Two pts
had preterm labor, 1 due to toxemia (twin pregnancy). One pregnancy was
complicated by high RV pressure (from conduit obstruction), and 1 by CHF
requiring hospitalization for the last month of pregnancy (no prior surgery).
The mean maternal Hb in pts with successful pregnancy was 14.9 ± 1.3 gms
vs 18.3 ± 2.1 gms in pts who terminated pregnancy (p = 0.01) and 16.4 ±
2.2 gms in pts with unsuccessful pregnancies (p = NS).
No pregnancy related maternal deaths occurred. The overall mean birth-
weight was 2.2 kg; 2.0 ± 0.7 kg for 7 offspring of cyanotic pts vs 3.1 ± 0.3 kg
for 2 offspring of pts post complete repair (p = 0.08). None of the offspring
had congenital heart disease.
Conclusion: Pregnancy in pts with complex PA can be successfully carried
out but there is an increased risk of fetal loss even without maternal hypoxia(mi~carriage rate 50%). Pre-pregnancy assessment of functional class, pul-
monary pressures, ventricular and conduit function and degree of cyanosis
should be established.
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1794-21 Angiotensin Converting Enzyme Inhibition in Adults
with Cyanotic Congenital Heart Disease
Michael J. Landzberg, Brian J. Morrison, Robert H. Pass, Laurence J. Sloss Boston
Adult Congenital Heart Service, Brigham, MA: Women's and Children's Hospitals,
Boston, MA
Adult patients (pts) with cyanotic congenital heart disease (CCHD) and eleva-
tion (t) in pulmonary vascular resistance IPVR) may have a marked decrease
in exercise capacity (EX) and quality of life due to intravascular volume over-
load, ventricular dysfunction and cyanosis-related morbidity. Concerns of in-
creasing right-to-Ieft shunting and cyanosis have limited characterization of
the safety and effects of angiotensin converting enzyme inhibition (ACE I) in
these pts.
We evaluated ACEI in 7 symptomatic adults (ages 29-36 yrs) with CCHD
and tPVR from 6/92 to 6/94. Intracardiac shunting was present at the ven-
tricular level (single ventricle, double outlet right ventricle) in 3 pts, at the
atrial septum (Ebstein's malformation, peripheral pulmonary stenoses) in 2
pts, and at both levels IAV canal defect) in 2 pts. All pts had marked exer-
cise incapacity; 6/7 were candidates for heart-lung transplantation. Baseline
serum hemoglobin (Hgbl. oxygen saturation (02sat) and 6 minute walking
capacity (6 min) were compared before and after 6 weeks of ACEI. Baseline
Hgb was 2:6 gm/dl (19.3 ± 1.7) and 02sat was :::;:90% (79 ± 4) in all pts. ACEI
caused no decrease in 02sat or increase in Hgb in any pt. When compared
to baseline, EX increased 2:30% (6 min: 326 ± 129 vs 441 ± 160 yds) with
ACEI in 5/5 pts (p = 0.01). All pts noted subjective functional improvement
with ACEI; during treatment 3/6 pts removed themselves from consideration
for organ transplantation and remain well.
Our preliminary findings suggest that short-term ACEI is safe and may im-
prove exercise capacity and quality of life in adult pts with CCHD and t PVR.
Further investigation is required to elucidate the mechanisms of these ben-
efits and to determine the long-term effects of ACEI in this cohort.
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Local Delivery of Nitrosated Albumin to Stenosed
and Damaged Coronary Arteries Inhibits Platelet
Deposition and Thrombosis
John D. Folts 1, John F. Kaeney 2, Joseph Loscalzo 2 1Department of Medicine,
University of Wisconsin, Madison, WI; 2 Department of Medicine, Boston University.
Boston, MA
The ideal agent to inhibit interactions between platelets and damaged arte-
rial walls, such as after angioplasty or atherectomy, should be potent locally
but not cause systemic bleeding. We have previously shown that nitrosated
albumin (NO-SA) given IV inhibits circulating platelets, abOlishes cyclic flow
reductions (CFR's), due to acute platelet thrombus formation (APTF) in me-
chanically stenosed coronary arteries (MSCA) with severe medial damage
in dogs. Seven anesthetized dogs were prepared with MSCA in both the
circumflex and the LAD branches, and CFR's occurred in both arteries. A
Wolinsky perforated balloon catheter was placed in the stenosed circum-
flex (n = 5) or in the stenosed LAD (n ~ 2), when CFR's were occurring,
and 3 ml of 200 IlM/ml SA-NO was injected at 3 atmospheres for 30 sec-
onds. When flow was restored, the CFR's were abolished in six dogs and
decreased significantly in size and frequency in the seventh. However, the
CFR's in the untreated stenosed artery continued unchanged. There was no
change in blood pressure from the application of SA-NO. Balloon inflations
with saline for the same time and pressure had no effect on the CFR's. The
protective effect lasted for one hour when the experiment was terminated.
Ex vivo platelet aggregation studies done before and 30 minutes after the
SA-NO treatment showed no changes. Since the CFR's continued in the un-
treated artery and ex vivo platelet aggregation did not change, we conclude
that the SA-NO had a local protective effect with no systemic platelet inhi-
bition. Early and late failure of angioplasty is thought to be due, in part, to
immediate platelet deposition on the fresh medial injury causing thrombo-
sis and release of growth factors for intimal hyperplasia. Coating the acutely
damaged arterial wall after angioplasty with SA-NO, may diminish platelet
deposition and the presence of NO molecules may inhibit smooth muscle
mediated elastic recoil at the angioplasty site, thus reducing the incidence
of restenosis.
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1793-51 Reducing Platelet Adhesion Following Angioplasty:
The Effects of Platelet Encapsulated 1I0prost
Delivered Locally or Intravenously
Adrian P Banning, William J. Penny, Malcolm J. LeWis, Neville Crawford 1
University Hospital of Wales, Cardiff, London, UK: 1 Biochemistry Dept. Royal Free
Hospital, London. UK
Reducing platelet (pit) deposition following balloon angioplasty may reduce
immediate procedural complications and limit subsequent neo-intimal hyper-
plasia. We electro-encapsulated the stable prostacyclin analogue, iloprost
(IL) (which inhibits pit-pit interactions without affecting pit adhesion to colla-
gen). into autologous pits and studied pit recruitment following balloon in-
jury. Pigs In ~ 16) underwent bilateral carotid angioplasty after pre-injection
of l111ndium labelled pits and were randomised at the time of angioplasty
according to method of pit delivery:- Group 1) IL pits delivered locally using
a double balloon catheter 2) IL pits as an iv bolus at the time of angioplasty
3) Sham electroporated pits delivered locally 4) Sham pits delivered locally
with the addition of free IL to the suspension (in an amount equivalent to
twice that present in the IL pits). Animals were sacrificed at 1.5 hrs post an-
gioplasty and sections (n = 2 each artery) were classified by histology into
minimal (M) or deep injury (D) (ruptured internal elastic lamina)
